History of drug use in allogeneic hematopoietic cell transplant recipients-Reference-Cited by-同舟云学术

History of drug use in allogeneic hematopoietic cell transplant recipients

Published:2020-09-17 Issue:3 Volume:56 Page:581-585
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Abou-Ismail Mouhamed Yazan,Ravi Gayathri,Fu Pingfu^ORCID,Cao Shufen,Vuyyala Sowjanya,Caimi Paolo,Kolk Merle,Ferrari Nicole,Boughan Kirsten,Cooper Brenda^ORCID,Gallogly Molly,Otegbeye Folashade^ORCID,Tomlinson Benjamin,de Lima Marcos^ORCID,Metheny Leland^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-020-01058-z.pdf

Reference15 articles.

1. Peccatori J, Ciceri F. Allogeneic stem cell transplantation for acute myeloid leukemia. Haematologica. 2010:95:857–9.

2. Metheny L, de Lima M. Hematopoietic stem cell transplant with HLA-mismatched grafts: impact of donor, source, conditioning, and graft versus host disease prophylaxis. Expert Rev Hematol. 2019;12:47–60.

3. Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG, et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood. 2007;110:3784–92.

4. Martin PJ, Counts GW,Jr, Appelbaum FR, Lee SJ, Sanders JE, Deeg HJ. Life expeÿctancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol. 2010;28:1011–6.

5. Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106:2912–9.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correction: History of drug use in allogeneic hematopoietic cell transplant recipients;Bone Marrow Transplantation;2020-10-21